Delivery Order SPE2DB20D1100-SPE2DB24FB3G7
Award Date 4/17/24
Potential Completion Date 4/18/24
Potential Value $37K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,543,508 units of Bupropion HCL XL 300 mg tablets. The contract has a ceiling value of $13,933.62 and is a firm fixed-price delivery order that will run through May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 500 tablets of Bupropion HCL XL 300 mg. The contract has an ultimate completion date of April 28, 2025 and a ceiling value of $9,771.22. The contract is not set-aside and was awarded on April 25, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,916.92, is a firm fixed-price delivery order for the supply of 4565058004 - Bupropion HCL XL 300 mg Tablets in 500 count bottles. The contract has an ultimate completion date of July 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Bupropion HCL XL 300 mg tablets, with a ceiling value of $23,977.28 and a performance period through February 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This federal contract award is a delivery order valued at $66,036.93 awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the delivery of 4567584930 ! BUPROPION HCL XL 300 MG TABLET 500S, a pharmaceutical product, with a performance period ending on March 17, 2025. The contract is a firm fixed price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,876.60, is for the delivery of Bupropion HCL XL 300 mg tablets and is a firm fixed-price delivery order with a completion date of May 1, 2024. The contract is not designated as a set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $13,605.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. Amerisourcebergen, a major pharmaceutical distribution company, was awarded this firm-fixed-price delivery order for the supply of 4,564,542,994 units of Bupropion HCl XL 300 mg tablets. The award does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,596.22, is for the delivery of bupropion HCL XL 300 mg tablets. The contract is a firm fixed-price delivery order that runs through January 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,981,495 units of Bupropion HCl XL 300 mg tablets. The $3,363.79 contract has a period of performance through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $76,155.70, is a firm fixed price delivery order for the supply of Bupropion HCL XL 300 mg tablets. The award does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...